Thematische Bibliographien / Genetic risk factor / Bücher

Bücher zum Thema „Genetic risk factor“

Um die anderen Arten von Veröffentlichungen zu diesem Thema anzuzeigen, folgen Sie diesem Link: Genetic risk factor.
Autor: Grafiati
Veröffentlicht am 7. Juli 2024

Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an

Wählen Sie eine Art der Quelle aus:

Machen Sie sich mit Top-50 Bücher für die Forschung zum Thema "Genetic risk factor" bekannt.

Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.

Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.

Sehen Sie die Bücher für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.

1

Petrakis, Peter L. Alcoholism, and inherited disease. Rockville, Md: U.S. Dept. of Health and Human Services, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute on Alcohol Abuse and Alcoholism, 1985.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Young, Ian D. Introduction to risk calculation in genetic counselling. Oxford: Oxford University Press, 1991.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

J, Alberts Mark, Hrsg. Genetics of cerebrovascular disease. Armonk, NY: Futura Pub. Co., 1999.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Uri, Goldbourt, De Faire Ulf und Berg Kåre, Hrsg. Genetic factors in coronary heart disease. Dordrecht: Kluwer Academic, 1994.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Offit, Kenneth. Clinical cancer genetics: Risk counseling and management. New York: Wiley-Liss, 1998.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Kåre, Berg, Hrsg. Genetic approaches of coronary heart disease and hypertension. Berlin: Springer-Verlag, 1991.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Garte, Seymour J. Genetic susceptibility to cancer. Boston: Kluwer Academic, 1998.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Symposium on Phenotypic Variation in Populations: Relevance to Risk Assessment (1986 Brookhaven National Laboratory). Phenotypic variation in populations: Relevance to risk assessment. New York: Plenum Press, 1988.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

A, Levin Morris, und Strauss Harlee S, Hrsg. Risk assessment in genetic engineering. New York: McGraw-Hill, 1991.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Young, Ian D. Introduction to risk calculation in genetic counseling. 2. Aufl. Oxford [England]: Oxford University Press, 1999.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
11

Young, Ian D. Introduction to risk calculation in genetic counseling. 3. Aufl. Oxford: Oxford University Press, 2007.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
12

Marin, Noelle. Ovarian cancer: The signs, symptoms, treatments, and genetic risk factors. [United States]: Fort Press, 2010.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
13

Seshadri, Sudha, und Stéphanie Debette. Risk factors for cerebrovascular disease and stroke. Oxford: Oxford University Press, 2016.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
14

Gould, Randi L. Cancer and genetics: Answering your patients' questions. Huntington, NY: PRR, 1997.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
15

1960-, Foulkes William D., und Hodgson S. V, Hrsg. Inherited susceptibility to cancer: Clinical, predictive, and ethical perspectives. Cambridge: Cambridge University Press, 1998.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
16

Batsheva, Bonné-Tamir, und Adam Avinoam, Hrsg. Genetic diversity among Jews: Diseases and markers at the DNA level. New York: Oxford University Press, 1992.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
17

Bland, Jeffrey. Genetic nutritioneering. Los Angeles: Keats Pub., 1998.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
18

Brener, Milton E. Evolution and empathy: The genetic factor in the rise of humanism. Jefferson, N.C: McFarland & Co., 2008.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
19

Hiroshi, Hiai, und Hino Okio, Hrsg. Animal models of cancer predisposition syndromes. Basel: Karger, 1999.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
20

Epigenetics in Cancer Prevention: Early Detection and Risk Assessment Workshop (2001 Bethesda, Md.). Epigenetics in cancer prevention: Early detection and risk assessment. New York: New York Academy of Sciences, 2003.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
21

Obe, G. Cancer risk evaluation: Methods and trends. Weinheim: Wiley-Blackwell, 2011.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
22

Morris, Joi L. Positive results: Making the best decisions when you're at high risk for breast or ovarian cancer. Amherst, N.Y: Prometheus Books, 2010.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
23

Teichler-Zallen, Doris. To test or not to test: A guide to genetic screening and risk. New Brunswick, N.J: Rutgers University Press, 2008.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
24

Teichler-Zallen, Doris. To test or not to test: A guide to genetic screening and risk. New Brunswick, N.J: Thorndike Press, 2009.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
25

V, Hodgson S., Hrsg. A practical guide to human cancer genetics. 3. Aufl. Cambridge: Cambridge University Press, 2007.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
26

Hodgson, S. V. A practical guide to human cancer genetics. Cambridge [England]: Cambridge University Press, 1993.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
27

Ueland, Per Magne, und Rima Rozen. MTHFR polymorphisms and disease. Georgetown, Tex: Landes Bioscience, 2005.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
28

Robert, Cloninger C., und Begleiter Henri, Hrsg. Genetics and biology of alcoholism. Plainview, N.Y: Cold Spring Harbor Laboratory Press, 1990.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
29

Seshadri, Sudha, und Stéphanie Debette, Hrsg. Risk Factors for Cerebrovascular Disease and Stroke. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199895847.001.0001.

Der volle Inhalt der Quelle
Annotation:
Risk Factors for Cerebrovascular Disease and Stroke describes environmental and genetic determinants for cerebrovascular disease and stroke from the perspective of an international group of neurologists, epidemiologists, and geneticists who are at the forefront of research and education on these issues. Unlike other books in the field, which solely deal with physiology, diagnosis, and management of stroke, this essential book discusses prevention factors as well as the causes. This unique book takes a comprehensive approach to risk prediction while integrating epidemiological, genetic, and statistical principles explained in a way that is easy for the clinical trainee to understand. The section on genetic risk factors for various types of stroke is unique in its depth and up-to-date information. Clinicians, residents, fellows and academics in neurology, geriatrics, internal medicine, epidemiology, genetics, public health professionals, and preventative cardiologists, as well as nurses, practitioners and physician assistants will find this a handy source for years to come.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
30

Hinks, Anne, und Wendy Thomson. Genetics of juvenile rheumatic diseases. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0043.

Der volle Inhalt der Quelle
Annotation:
Juvenile rheumatic diseases are heterogeneous, complex genetic diseases; to date only juvenile idiopathic arthritis (JIA) has been extensively studied in terms of identifying genetic risk factors. The MHC region is a well-established risk factor but in the last few years candidate gene and genome-wide association studies have been utilized in the search for non-HLA risk factors. There are now an additional 12 JIA susceptibility loci with evidence for association in more than one study. In addition, some subtype-specific associations are emerging. These risk loci now need to be investigated further using fine-mapping strategies and then appropriate functional studies to show how the variant alters the gene function. This knowledge will not only lead to a better understanding of disease pathogenesis for juvenile rheumatic diseases but may also aid in the classification of these heterogeneous diseases. It may identify new pathways for potential therapeutic targets and help in the prediction of disease outcome and response to treatment.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
31

Gaff, Clara, Louise Keogh und Elizabeth Lobb. Communicating genetic risk. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780198736134.003.0034.

Der volle Inhalt der Quelle
Annotation:
The discovery of cancer predisposing genetic mutations has heightened community awareness of the link between family history, genetic constitution, and personal risk. The component of an individual’s cancer risk that is due to their genetic make-up can be described as their ‘genetic risk’. Knowledge of genetic risk can assist both individuals with cancer and unaffected individuals to make decisions about healthcare and inform relatives who may share that genetic risk. Accordingly, patients seek advice about their risk and its implications and management from general practitioners (primary healthcare physician) or cancer specialists. In this chapter, we discuss the interlinked processes of risk assessment, risk perception, and risk communication in the context of genetic risk of cancer. While this is only one component of an individual’s risk of cancer—other factors including lifestyle, medical history, and environmental exposures—the principles of risk communication are applicable to each of these individual risk factors.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
32

Hinks, Anne, und Wendy Thomson. Genetics of juvenile rheumatic diseases. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199642489.003.0043_update_002.

Der volle Inhalt der Quelle
Annotation:
Juvenile rheumatic diseases are heterogeneous, complex genetic diseases; to date only juvenile idiopathic arthritis (JIA) has been extensively studied in terms of identifying genetic risk factors. The MHC region is a well-established risk factor but in the last few years candidate gene and large-scale genome-wide association studies have been utilized in the search for non-HLA risk factors. There are now 17 JIA susceptibility loci which reach the genome-wide significance threshold for association and a further 7 regions with evidence for association in more than one study. In addition, some subtype-specific associations are emerging. These risk loci now need to be investigated further using fine-mapping strategies and then appropriate functional studies to show how the variant alters the gene function. This knowledge will not only lead to a better understanding of disease pathogenesis for juvenile rheumatic diseases but may also aid in the classification of these heterogeneous diseases. It may identify new pathways for potential therapeutic targets and help in the prediction of disease outcome and response to treatment.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
33

Hinks, Anne, und Wendy Thomson. Genetics of juvenile rheumatic diseases. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199642489.003.0043_update_003.

Der volle Inhalt der Quelle
Annotation:
Juvenile rheumatic diseases are heterogeneous, complex genetic diseases; to date only juvenile idiopathic arthritis (JIA) has been extensively studied in terms of identifying genetic risk factors. The MHC region is a well-established risk factor but in the last few years candidate gene and large-scale genome-wide association studies have been utilized in the search for non-HLA risk factors. There are now 17 JIA susceptibility loci which reach the genome-wide significance threshold for association and a further 7 regions with evidence for association in more than one study. In addition, some subtype-specific associations are emerging. These risk loci now need to be investigated further using fine-mapping strategies and then appropriate functional studies to show how the variant alters the gene function. This knowledge will not only lead to a better understanding of disease pathogenesis for juvenile rheumatic diseases but may also aid in the classification of these heterogeneous diseases. It may identify new pathways for potential therapeutic targets and help in the prediction of disease outcome and response to treatment.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
34

Putaala, Jukka, und Nicolas Martinez-Majander. Risk factors. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198722366.003.0002.

Der volle Inhalt der Quelle
Annotation:
Risk factors in young-onset stroke include both traditional and unconventional as well as both chronic and temporal ones. In young patients, unconventional risk factors such as oral contraceptive use, antiphospholipid antibodies, genetic thrombophilia, acute infections, illicit drug use, and migraine may play a greater role than in elderly patients. However, recent large studies have challenged this traditional view suggesting that young adult stroke would occur mostly due to such unconventional risk factors. These studies have shown a high prevalence of in particular modifiable behavioural risk factors, including physical inactivity, high-risk alcohol consumption, and smoking. Since consequences of a young-onset stroke are greater regarding quality-adjusted life and economic impact, detection and treatment of especially modifiable risk factors are of paramount importance. This chapter reviews the burden of both traditional and less well-documented risk factors in young ischaemic stroke patients and discusses their strength of evidence and mechanisms of association.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
35

Holdt, Lesca M., und Daniel Teupser. Genetic background of atherosclerosis and its risk factors. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199656653.003.0002.

Der volle Inhalt der Quelle
Annotation:
This chapter is concerned with how atherosclerosis risk is modulated by a complex interplay between genetic and environmental risk factors. The contribution of genetics to the variability of atherosclerosis risk is estimated as 50%. Recent genome-wide association studies have led to the identification of over 50 gene variants which modulate atherogenesis. Risk factors for atherosclerosis are also partly genetically determined and some of the variants which play a role in atherogenesis overlap with those modulating its risk factors. However, the current relevance of these findings for clinical practice is limited, mainly due to the small effect sizes of identified risk variants with insufficient discriminatory power, and a large portion of the genetic contribution to atherosclerosis is still unknown. The major promise therefore lies in understanding the pathophysiology of newly identified genes with the perspective of novel therapeutic approaches.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
36

Choy, Wai Nang. Genetic Toxicology and Cancer Risk Assessment. Informa Healthcare, 2001.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
37

Choy, Wai Nang. Genetic Toxicology and Cancer Risk Assessment. Taylor & Francis Group, 2001.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
38

Choy, Wai Nang. Genetic Toxicology and Cancer Risk Assessment. Taylor & Francis Group, 2001.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
39

Choy, Wai Nang. Genetic Toxicology and Cancer Risk Assessment. Taylor & Francis Group, 2001.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
40

Choy, Wai Nang. Genetic Toxicology and Cancer Risk Assessment. Taylor & Francis Group, 2001.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
41

Choy, Wai Nang. Genetic Toxicology and Cancer Risk Assessment. Taylor & Francis Group, 2001.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
42

Offit, Kenneth. Clinical Cancer Genetics: Risk Counseling and Management. Not Avail, 2008.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
43

Garte, Seymour. Genetic Susceptibility to Cancer. Springer, 2011.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
44

Garte, Seymour. Genetic Susceptibility to Cancer. Springer London, Limited, 2012.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
45

Garte, Seymour. Genetic Susceptibility to Cancer. Springer London, Limited, 2013.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
46

Choy, Wai Nang. Genetic Toxicology and Cancer Risk Assessment. Taylor & Francis Group, 2001.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
47

Genetic toxicology and cancer risk assessment. New York: Marcel Dekker, 2001.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
48

Bianchi, Filippo, und Salvatore De Rossi. Aneuploidy: Etiology, Disorders, and Risk Factors. Nova Science Publishers, Incorporated, 2012.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
49

CLARK, ROSS D. Medical, Genetic & Behavioral Risk Factors of the Sporting Breeds. Xlibris, 2017.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
50

Woodhead, Avril. Phenotypic Variation in Populations:Relevance to Risk Assessment (Basic Life Sciences). Springer, 1988.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
Die Auswahlen zum Thema "Genetic risk factor" für andere Quellenarten können Sie auch interessieren:
Zeitschriftenartikel Dissertationen
Wir bieten Rabatte auf alle Premium-Pläne für Autoren, deren Werke in thematische Literatursammlungen aufgenommen wurden. Kontaktieren Sie uns, um einen einzigartigen Promo-Code zu erhalten!

Zur Bibliographie